1Monk BJ,Im S,Wang J,et al. Rethinking the use of chemotherapy and radiotherapy after radical hysterectomy : a elinico-pathologic analysis of SWOG 8797/GOG 109 by the gynecologic oncology group [ J ]. Gynecol Oncol, 2005,96 (3) :721.
2Monk B J, Tian C, Rose PG, et al. Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma: analysis of two gynecologic oncology group (GOG) trials[J ]. Gynecol Oncol, 2007,105(2) :427.
3Rotman M,Sedlis A,Piedmonte MR,et al. A phase Ⅲ randomized trial of postoperative pelvic irradiation in stage I B cervical carcinoma with poor prognostic features:follow-up of a gynecologic oncology group study [ J ]. Int J Radiat Oncol Biol Phys ,2006,65 ( 1 ) : 169.
4Horn LC, Fischer U, Bilek K. Histopathological prognostic factors in primary surgically treated cervix carcinoma[ J]. Zentralbl Gynakol, 2001,123 ( 5 ) :266.
5Koukourakis MI, Tsoutsou PG, Sismanidou K, el al. Postoperative accelerated radiotherapy with cytoproteetion followed by three-dimensional conformal boost in patients with early endometrial/cervical cancer [J], Tumor, 2009, 95 (4) :455.
6Grigsby PW. Postoperative irradiation in cervical cancer: prognostic factors and outcome [ J ]. Radiat Med, 2004,22 (2) :106.
